Jason Gerberry analyst BAML

Currently out of the existing stock ratings of Jason Gerberry, 139 are a BUY (61.23%), 53 are a HOLD (23.35%), 35 are a SELL (15.42%).

Jason Gerberry

Work Performance Price Targets & Ratings Chart

Analyst Jason Gerberry works at BAML with a stock forecast success ratio of 58.52% fulfilled within 263.89 days on average. Previously, Jason Gerberry worked at LEERINK.

Jason Gerberry’s has documented 459 price targets and ratings displayed on 45 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ALKS, Alkermes Plc at 02-Jan-2024.

Wall Street Analyst Jason Gerberry

Analyst best performing recommendations are on CORI (CORIUM INTERNATIONAL).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $261 was fulfilled within 2 days with a profit of $32.55 (14.25%) receiving and performance score of 71.24.

Average potential price target upside

ABBV AbbVie AGN Allergan plc ALKS Alkermes Plc BHC Bausch Health Companies BLUE Bluebird bio BYSI BeyondSpring ENDP Endo International PLC FGEN FibroGen GLPG Galapagos NV ADR HZNP Horizon Pharma PLC IONS Ionis Pharmaceuticals JAZZ Jazz Pharmaceuticals PLC LLY Eli Lilly and Company MNK Mallinckrodt plc MRK Merck mpany MRTX Mirati Ther MYL Viatris PCVX Vaxcyte  TARS Tarsus Pharmaceuticals  TEVA Teva Pharma Industries Ltd ADR ALLO Allogene Therapeutics BMY Bristol-Myers Squibb Company HRTX Heron Therapeuti MNTA Momenta Pharmaceuticals PFE Pfizer AKRX Akorn ARNA Arena Pharmaceuticals AVDL Avadel Pharmaceuticals PLC CORI Corium International KRTX Karuna Therapeutics PRGO Perrigo Company PLC DICE Dice Molecules Holdings LLC FWP Forward Pharma A S VTRS Viatris OGN Organon ACLX Arcellx AERI Aerie Pharmaceuticals . AMTI Applied Molecular Transport  CARA Cara Therapeutic LYRA Lyra Therapeutics  CHRS Coherus BioSciences RLAY Relay Therapeutics  XENE Xenon Pharmaceuticals AXSM Axsome Therapeutics ARWR Arrowhead Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

189

$10.19 (5.70%)

181

22 days ago

9/13 (69.23%)

$20.33 (12.05%)

256

Buy

185

$6.19 (3.46%)

175

22 days ago

11/12 (91.67%)

$16.33 (9.68%)

140

Buy

195

$16.19 (9.05%)

180

22 days ago

7/10 (70%)

$26.33 (15.61%)

402

Hold

156

$-22.81 (-12.76%)

167

2 months 10 days ago

2/2 (100%)

$2.58 (1.68%)

109

Buy

173

$-5.81 (-3.25%)

122

2 months 17 days ago

1/3 (33.33%)

$21.76 (14.39%)

58

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jason Gerberry is most bullish on?

Potential upside of $14.59 has been obtained for IONS (IONIS PHARMACEUTICALS)

Which stock is Jason Gerberry is most reserved on?

Potential downside of -$55.89 has been obtained for KRTX (KARUNA THERAPEUTICS)

What Year was the first public recommendation made by Jason Gerberry?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?